
Eric Joseph Oligino MD FACC
Echocardiography, Nuclear Cardiology, Non-Invasive Cardiology, Vascular Medicine
Cardiologist at Cardiology PC
Join to View Full Profile
100 Retreat AveSuite 811Hartford, CT 06106
Phone+1 860-522-5712
Fax+1 860-520-4270
Dr. Oligino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 2010 - 2013
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2007 - 2010
- Uconn School Of MedicineClass of 2007
Certifications & Licensure
- CT State Medical License 2011 - 2026
- PA State Medical License 2007 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Registry for Diagnostic Medical SonographyRegistered Physician in Vascular Interpretation
- Certification Board of Nuclear CardiologyNuclear Cardiology
- National Board of EchocardiographyAdult Comprehensive Echocardiography
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013-2014
Publications & Presentations
PubMed
- Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infe...Emily Pei-Ying Lin, Chih-Yuan Hsu, Sanjay Mishra, Elizabeth A Griffiths, Brahm H Segal
Lancet Regional Health. Americas. 2025-04-01 - COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease.Melissa Y Y Moey, Cassandra Hennessy, Benjamin French, Jeremy L Warner, Matthew D Tucker
Translational Oncology. 2023-08-01 - 2 citationsRationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy.Anthony F Yu, Chau T Dang, Justine Jorgensen, Chaya S Moskowitz, Patricia DeFusco
Cardio-Oncology. 2023-03-09
Press Mentions
- Cardio-Oncology Program Receives Gold Standard CertificationJuly 21st, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: